Cannabis Suisse Corp.

CSUI

US13767A1034

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:36:47 2024-05-22 EDT			5-day change	1st Jan Change
0.0224 ^USD	0.00%		0.00%	-18.25%

04-12	Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
01-12	Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	CI

Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022

April 14, 2022 at 04:18 pm

Cannabis Suisse Corp. reported earnings results for the third quarter and nine months ended February 28, 2022. For the third quarter, the company reported net loss was USD 0.042854 million compared to USD 0.080644 million a year ago.
For the nine months, revenue was USD 0.00777 million compared to USD 0.05085 million a year ago. Net loss was USD 0.245682 million compared to USD 0.338663 million a year ago.

Latest news about Cannabis Suisse Corp.

Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	04-12	CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	01-12	CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-17	CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2023	23-09-12	CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	23-04-19	CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	23-02-21	CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022	22-12-14	CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2022	22-11-23	CI
Cannabis Suisse Corp. Auditor Raises 'Going Concern' Doubt	22-11-22	CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	22-04-14	CI
Cannabis Suisse Corp. Announces Management Changes	22-01-19	CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	22-01-14	CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2021	21-10-20	CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2021	21-09-06	CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter Ended February 28, 2021	21-04-19	CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter Ended November 30, 2020	21-01-19	CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2020	20-11-19	CI
Cannabis Suisse Corp. Announce Expansion Plans for Online Sales, Adding to CBD product lines with New Hemp Brands	20-09-21	CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter Ended February 29, 2020	20-06-03	CI
Cannabis Suisse Corp. Announces a New Two-Year Distribution Agreement	20-05-21	CI
Cannabis Suisse Launches Pre-Rolled Cannabis Joints Based on the V1 Cannabis Strain	20-05-11	CI
Cannabis Suisse’s Own Brand, Alpine Cannabis, Is Releasing A Product Line of Brand-New Cannabis Oils	20-04-29	CI
Cannabis Suisse Launches a New Retail Product	20-03-23	CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter Ended November 30, 2019	20-01-21	CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2019	19-12-03	CI

Chart Cannabis Suisse Corp.

Duration

Period

More charts

Company Profile

Cannabis Suisse Corp. is engaged in the business of production of over the counter (OTC) products, such as cannabidiol (CBD) oils, retail branded cigarettes and also some health-related supplements. The Company's products include Flavored Broad-Spectrum CBD Oils and CBD Isolate Tinctures with no tetrahydrocannabinol (THC). Flavored Broad-Spectrum CBD Oils products come in one fluid ounce (30 milliliters (ml)) bottles available in two flavors, such as Creme de Menthe and Cherry Vanilla. Its available CBD concentrations are 1500 milligrams (mg), 2500 mg and 3500 mg. CBD Isolate Tinctures with no THC products come in one fluid ounce (30 ml) bottles with 1000 mg CBD concentrations per bottle and 33.33 mg CBD per serving. CBD Tinctures are designed to have therapeutic effects.

Sector

Pharmaceuticals

More about the company